206 related articles for article (PubMed ID: 27637487)
1. Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development.
Copley-Merriman C; Zelt S; Clark M; Gnanasakthy A
Patient; 2017 Apr; 10(2):203-213. PubMed ID: 27637487
[TBL] [Abstract][Full Text] [Related]
2. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
Bagel J; Levi E; Tyring S; Knuckles ML
J Drugs Dermatol; 2014 Nov; 13(11):1374-9. PubMed ID: 25607705
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
4. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
Scheinfeld NS
Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
[No Abstract] [Full Text] [Related]
5. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison.
Pagliarello C; Fabrizi G; Fantini C; Cortelazzi C; Boccaletti V; Annessi G; Zampetti A; Feliciani C; Di Nuzzo S
Eur J Dermatol; 2015 Apr; 25(2):206-8. PubMed ID: 25786341
[No Abstract] [Full Text] [Related]
6. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
7. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
[No Abstract] [Full Text] [Related]
9. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U;
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
[TBL] [Abstract][Full Text] [Related]
12. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
Newman MD; Silverberg NB
Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490
[TBL] [Abstract][Full Text] [Related]
13. Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.
Del Rosso JQ
Cutis; 2014 Sep; 94(3):127-34. PubMed ID: 25279474
[TBL] [Abstract][Full Text] [Related]
14. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Williams Z; Peyri Rey J; Svensson A; Toole J; Wozel G
Dermatology; 2006; 213(4):319-26. PubMed ID: 17135738
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.
Eichenfield LF; Ganslandt C; Kurvits M; Schlessinger J
Pediatr Dermatol; 2015; 32(1):28-35. PubMed ID: 25412565
[TBL] [Abstract][Full Text] [Related]
16. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: an open-label study.
Park JM; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim BS; Kim MB
J Am Acad Dermatol; 2013 Sep; 69(3):492-3. PubMed ID: 23957979
[No Abstract] [Full Text] [Related]
18. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
Feldman SR; Levi E; Pathak P; Kakatkar S; Balkrishnan R
J Med Econ; 2013 Dec; 16(12):1405-13. PubMed ID: 24063352
[TBL] [Abstract][Full Text] [Related]
19. [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].
Henry F; Flagothier C; Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2006 Mar; 61(3):139-41. PubMed ID: 16680996
[TBL] [Abstract][Full Text] [Related]
20. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
Cassano N; Vena GA
Acta Derm Venereol; 2007; 87(1):85-6. PubMed ID: 17225026
[No Abstract] [Full Text] [Related]
[Next] [New Search]